Morning Trend | CMS steadily rebounds, can the pharmaceutical sector open a rebound window?

CMS (867.HK) performed outstandingly on the 16th, with funds actively lifting the stock price in the early market, and the bullish atmosphere continued until the close. The stock price closed higher on the daily line, with recent trading volume expanding positively, and a local rebound chain emerging within the pharmaceutical sector. There are signs of tentative capital returning in batches, with increased follow-up buying. On the news front, the company's third-quarter earnings guidance continues to release positive signals. The commercialization progress of new drugs is smooth, leading to some capital spilling over into pharmaceutical growth stocks. Innovative drugs are under regulatory scrutiny, and the sector has recently received marginal policy benefits. The daily line has seen continuous volume expansion, and trading has become significantly active after breaking through the consolidation platform, with both 8-hour and 24-hour trends continuing to rise. The technical RSI indicator shows a short-term bias towards strength, and there may be fluctuations and repeated demand during the trading session. Overall, the pharmaceutical sector is still in a bottoming phase, and if the main capital continues to increase its control and volume, the rebound window is expected to open fully. In the short term, one should still guard against the pressure of a pullback after a rise and pay attention to whether the market can continue to attract incremental capital. The expansion of the market needs to rely on sustained volume and policy follow-up. Investors should focus on changes in capital inflow and flexibly grasp the rhythm of the rebound and volatility risks